| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 10/19/2006 | CA2603701A1 1,4-substituted piperazine derivative |
| 10/19/2006 | CA2602721A1 4-(pyrid-2-yl) amino substituted pyrimidine as protein kinase inhibitors |
| 10/19/2006 | CA2601986A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 10/19/2006 | CA2599479A1 3,4-dihydro-benzo[e][1,3]oxazin-2-ones |
| 10/18/2006 | EP1712550A2 Substituted triazole diamine derivatives as kinase inhibitors |
| 10/18/2006 | EP1711495A2 Quinoline, quinazoline, pyridine and pyrimidine counds and their use in the treatment of inflammation, angiogenesis and cancer |
| 10/18/2006 | EP1711494A1 Aryl substituted heterocycles, method for production and use thereof as medicaments |
| 10/18/2006 | EP1711493A2 Crystalline forms of zolmitriptan |
| 10/18/2006 | EP1711492A1 Substituted quinolines and their use as mycobacterial inhibitors |
| 10/18/2006 | EP1711491A1 Heterocyclic derivatives as gpcr receptor agonists |
| 10/18/2006 | EP1711480A1 Novel long-working beta-2-agonists and use thereof as medicaments |
| 10/18/2006 | EP1711467A2 Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof |
| 10/18/2006 | EP1711184A1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 10/18/2006 | EP1423112B1 A combination of quetiapine and zolmitriptan |
| 10/18/2006 | CN1849325A Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting prot ein kinases |
| 10/18/2006 | CN1849321A Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 10/18/2006 | CN1849318A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds |
| 10/18/2006 | CN1849317A Crystal of heterocyclic compound |
| 10/18/2006 | CN1849302A 1, 3-disubstituted azetidine derivatives for use as CCR-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 10/18/2006 | CN1849122A Method of treating cancer using fpt inhibitors and at least two antineoplastic agents |
| 10/18/2006 | CN1849121A Piperazine derivatives as bradyknin antagonist |
| 10/18/2006 | CN1849120A 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 10/18/2006 | CN1280278C Method for producing asymmetrical 4,6-bis (aryloxy) pyrimidine derivatives |
| 10/18/2006 | CN1280277C Diamide invertebrate pest control agents contg. non-aromatic heterocyclic ring |
| 10/18/2006 | CN1280269C Aliphatic nitrogenous five-membered ring compounds |
| 10/18/2006 | CN1280267C Sulfonylaminocarboxylic acids |
| 10/18/2006 | CN1280259C Aryl aniline beta-2 adrenergic receptor agonists |
| 10/17/2006 | US7122675 Gamma secretase inhibitors |
| 10/17/2006 | US7122665 Heterocyclic compounds |
| 10/17/2006 | US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 10/17/2006 | US7122557 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents |
| 10/17/2006 | US7122556 Phenylalanine enamide derivatives |
| 10/17/2006 | US7122547 Anthranilic acid amides and the use thereof as medicaments |
| 10/17/2006 | US7122545 Imidazo-benzothiazoles |
| 10/17/2006 | US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 10/17/2006 | US7122542 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 10/17/2006 | US7122538 Neuroleptic agents for treating schizophrenia, psychological disorders, depression; 5-(4-Chlorophenyl)-thiophene-2-sulfonic acid (8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)amide |
| 10/17/2006 | US7121707 Illuminated electrical cords and outlets |
| 10/17/2006 | CA2395705C Substituted phenyl-piperazine derivatives, their preparation and use |
| 10/17/2006 | CA2238818C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 10/17/2006 | CA2238817C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 10/17/2006 | CA2236357C 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one derivatives for use as 5-ht4 or h3 receptor ligands |
| 10/12/2006 | WO2006108107A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors |
| 10/12/2006 | WO2006107062A2 Benzimidazole derivative and use as angiotensin ii antagonist |
| 10/12/2006 | WO2006106963A1 Triamine derivative |
| 10/12/2006 | WO2006106812A1 Propane-1,3-dion derivative or salt thereof |
| 10/12/2006 | WO2006106778A1 Bcrp/abcg2 inhibitor |
| 10/12/2006 | WO2006106427A1 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
| 10/12/2006 | WO2006106426A1 An oxindole oxazolidinone as antibacterial agent |
| 10/12/2006 | WO2006106425A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors |
| 10/12/2006 | WO2006106416A1 PYRIDIL-LACTAMS AND THEIR USE 5 -HTl RECEPTORS LIGAN |
| 10/12/2006 | WO2006106307A1 Pyrimidine derivatives for use as anticancer agents |
| 10/12/2006 | WO2006106306A1 Pyrimidines as igf-i inhibitors |
| 10/12/2006 | WO2006078283A3 Quinoxaline inhibitors of hedgehog signalling |
| 10/12/2006 | WO2006063281A3 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation |
| 10/12/2006 | WO2006022954A3 Benzoureas having anti-diabetic activity |
| 10/12/2006 | WO2005123703A3 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 10/12/2006 | US20060229349 7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
| 10/12/2006 | US20060229348 Oxindole oxazolidinone as antibacterial agent |
| 10/12/2006 | US20060229343 Pyrrolidine oxadiazole-and thiadiazole oxime derivatives being oxytocin receptor antagonists |
| 10/12/2006 | US20060229335 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a |
| 10/12/2006 | US20060229330 4-aminopyrimidine-5-one derivatives |
| 10/12/2006 | US20060229317 Substituted heterocyclic compounds |
| 10/12/2006 | US20060229316 Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them |
| 10/12/2006 | US20060229312 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 10/12/2006 | US20060229308 Substituted pyrirmidin-4-ylamine analogues as vanilloid receptor ligands |
| 10/12/2006 | US20060229297 (THIO) Carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 10/12/2006 | US20060229295 Amide derivatives |
| 10/12/2006 | US20060229280 2-(2,2 -Dimethylpentyl)-4-(7-methoxy-1, 3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonylmethyl)-pyrroldine-3-carboxylic acid; cardiovascular disorders, raynaud's disease, ischemia, hypotensive agent; with other cardiovascular agents |
| 10/12/2006 | US20060229205 Herbicidal heterocycles |
| 10/12/2006 | US20060226766 Electroluminescent device |
| 10/12/2006 | CA2603943A1 An oxindole oxazolidinone as antibacterial agent |
| 10/12/2006 | CA2603939A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors |
| 10/12/2006 | CA2603899A1 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
| 10/12/2006 | CA2603826A1 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 10/12/2006 | CA2603250A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors |
| 10/12/2006 | CA2602624A1 Benzimidazole derivative and use as angiotensin ii antagonist |
| 10/12/2006 | CA2602467A1 Bcrp/abcg2 inhibitor |
| 10/12/2006 | CA2602372A1 Pyrimidine derivatives for use as anticancer agents |
| 10/12/2006 | CA2602228A1 Triamine derivative |
| 10/11/2006 | EP1710793A1 Metal chelate compounds and high capacity optical recording medium using the compounds |
| 10/11/2006 | EP1709965A2 Methods of treating cytokine mediate diseases |
| 10/11/2006 | EP1709051A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 10/11/2006 | EP1709044A2 Oxazolidinone-quinolone hybrid antibiotics |
| 10/11/2006 | EP1709035A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes |
| 10/11/2006 | EP1709028A1 Fused heteroaryl derivatives and their use as p38 kinase inhibitors |
| 10/11/2006 | EP1709017A1 Urea derivatives |
| 10/11/2006 | EP1709006A1 Benzimidazole derivatives |
| 10/11/2006 | EP1708996A1 Fused heteroyral derivatives for use as p38 kinase inhibitors |
| 10/11/2006 | EP1708713A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 10/11/2006 | EP1708703A2 Chemokine receptor binding compounds |
| 10/11/2006 | EP1708702A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 10/11/2006 | EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 10/11/2006 | EP1478629B1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials |
| 10/11/2006 | EP0944619B1 Novel integrin receptor antagonists |
| 10/11/2006 | CN1845924A Arylamine-substituted quinazolinone compounds |
| 10/11/2006 | CN1845923A Intermediate products for producing oxazolidinone-quinolone hybrids |
| 10/11/2006 | CN1845922A Benzimidazolone compounds having 5-HT4 receptor agonistic activity |
| 10/11/2006 | CN1845921A Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPP-IV inhibitors |
| 10/11/2006 | CN1845915A Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |